Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease

Authors not listed

Augusta University · 2026

Abstract

The goal of this clinical trial is to determine whether the extra-virgin olive oil (EVOO) phenolic dietary supplement can improve memory function and modulate biomarkers among individuals with mild cognitive impairment (MCI). The main questions it aims to answer are: * Does dietary supplementation with EVOO phenolics improve cognitive function? * What would be the effect of the EVOO dietary supplement on other MCI-related biomarkers, including vascular function and biological pathways? Researchers will compare the EVOO dietary supplements with a placebo (a look-alike substance that contains no EVOO phenolics) Participants will: * Take EVOO dietary supplements or a placebo daily for 6 months * Visit the study site during the 6-month study for screening and testing.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2026). Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease. <em>Augusta University</em>. https://clinicaltrials.gov/study/NCT07741773
Vancouver
Anonymous. Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease. Augusta University. 2026.
BibTeX
@misc{anon2026Dietar, title = {Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease}, author = {Anonymous}, journal = {Augusta University}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings